-
公开(公告)号:US20170281692A1
公开(公告)日:2017-10-05
申请号:US15625715
申请日:2017-06-16
申请人: REBIOTIX, INC.
IPC分类号: A61K35/74 , C12Q1/04 , A61K35/741 , A61K35/742 , A61K9/00 , A61K35/744 , A61K35/747 , A01N1/02 , A61K47/10 , A61K35/38
摘要: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
-
公开(公告)号:US20150216917A1
公开(公告)日:2015-08-06
申请号:US14689464
申请日:2015-04-17
申请人: REBIOTIX, INC.
IPC分类号: A61K35/744 , A61K35/742 , A61K35/74
CPC分类号: A61K35/74 , A01N1/021 , A01N1/0284 , A61K9/0031 , A61K9/0053 , A61K35/38 , A61K35/741 , A61K35/742 , A61K35/744 , A61K35/747 , A61K47/10 , A61K2201/06 , A61P1/00 , B65B7/02 , B65B25/00 , C12N1/20 , C12Q1/04 , Y02A50/401 , Y02A50/463
摘要: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
-
公开(公告)号:US20170281693A1
公开(公告)日:2017-10-05
申请号:US15630234
申请日:2017-06-22
申请人: REBIOTIX, INC.
IPC分类号: A61K35/74 , C12Q1/04 , A61K35/741 , A61K35/742 , A61K9/00 , A61K35/744 , A61K35/747 , A01N1/02 , A61K47/10 , A61K35/38
CPC分类号: A61K35/74 , A01N1/021 , A01N1/0284 , A61K9/0031 , A61K9/0053 , A61K35/38 , A61K35/741 , A61K35/742 , A61K35/744 , A61K35/747 , A61K47/10 , A61K2201/06 , A61P1/00 , B65B7/02 , B65B25/00 , C12N1/20 , C12Q1/04 , Y02A50/401 , Y02A50/463
摘要: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
-
公开(公告)号:US20160354414A1
公开(公告)日:2016-12-08
申请号:US15239287
申请日:2016-08-17
申请人: REBIOTIX, INC.
IPC分类号: A61K35/74 , A01N1/02 , A61K35/744 , A61K35/742 , A61K47/10 , A61K9/00
CPC分类号: A61K35/74 , A01N1/021 , A01N1/0284 , A61K9/0031 , A61K9/0053 , A61K35/38 , A61K35/741 , A61K35/742 , A61K35/744 , A61K35/747 , A61K47/10 , A61K2201/06 , A61P1/00 , B65B7/02 , B65B25/00 , C12N1/20 , C12Q1/04 , Y02A50/401 , Y02A50/463
摘要: Microbiota restoration therapy compositions and methods for manufacturing, processing, and/or delivering microbiota restoration therapy compositions are disclosed. An example method for manufacturing a microbiota restoration therapy composition may include collecting a human fecal sample and adding a diluent to the human fecal sample to form a diluted sample. The diluent may include a cryoprotectant. The method may also include mixing the diluted sample with a mixing apparatus and filtering the diluted sample. Filtering may form a filtrate. The method may also include transferring the filtrate to a sample bag and sealing the sample bag.
-
-
-